Literature DB >> 7669958

Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass.

S G De Hert1, M M Moens, P G Jorens, G L Delrue, R J DePaep, K M Vermeyen.   

Abstract

OBJECTIVE: To compare the hemodynamic effects, pharmacokinetic profiles, and the need for vasoactive agents between a low (20 micrograms/kg during 15 minutes [group 1; n = 10]) and a high (40 micrograms/kg during 15 minutes [group 2; n = 10]) loading dose of milrinone.
DESIGN: Prospective, randomized, double-blind.
SETTING: University hospital. PARTICIPANTS: Twenty patients scheduled for elective coronary artery surgery.
INTERVENTIONS: Weaning from CPB was achieved using a strict protocol. After atrioventricular pacing at 90 beats per minute and preload optimalization, a first weaning attempt was started with only calcium and nitroglycerin as support. If this attempt was unsuccessful (cardiac index < 2L/min/m2), CPB was reinitiated and weaning level 2 was prepared, consisting of inotropic support with milrinone. Patients received either the low (group 1) or the high (group 2) loading dose of milrinone. After the end of the loading dose, a continuous infusion of milrinone of 0.5 micrograms/kg/min was started in both groups.
MEASUREMENTS AND MAIN RESULTS: Both groups were comparable regarding preoperative and intraoperative data. Hemodynamic data were comparable in both groups at each time of measurement (p = 0.941). The need for vasoactive medication (norepinephrine [NE]) in order to keep mean arterial pressure > or = 50 mm Hg was significantly higher in group 2 (p = 0.004). Need for NE during the loading infusion was 9.6 +/- 4.9 micrograms (mean +/- SEM) in group 1 and 41.6 +/- 7.6 micrograms in group 2 (p = 0.004). Need for NE during the immediate post-CPB period was also higher in group 2 (16.0 +/- 10.4 micrograms in group 1 and 232.5 +/- 82.8 micrograms in group 2 (p = 0.002)). Plasma clearance of milrinone after CPB was less in both groups than in healthy volunteers. However, clearance of milrinone was significantly higher in group 2 (p = 0.006), and consequently, half-life of milrinone was significantly less in group 2 (p = 0.007).
CONCLUSIONS: The present results demonstrate that when milrinone is used during weaning from CPB, a loading dose of 20 micrograms/kg provided to similar hemodynamic support a loading dose of 40 micrograms/kg. The need for vasoconstrictive medication was significantly less in the group with the low loading dose.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669958     DOI: 10.1016/s1053-0770(05)80319-2

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  6 in total

1.  Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease.

Authors:  Gonzalo Garcia Guerra; Ari R Joffe; Ambikaipakan Senthilselvan; Demetrios J Kutsogiannis; Christopher S Parshuram
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

2.  Use of milrinone in critically ill children.

Authors:  Teresa Bishara; Winnie T W Seto; Angela Trope; Christopher S Parshuram
Journal:  Can J Hosp Pharm       Date:  2010-11

3.  Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.

Authors:  Winnie Vogt
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

4.  Effect of arterial oxygen tension during reperfusion on myocardial recovery in patients undergoing valvular heart surgery.

Authors:  Jeong-Soo Lee; Jong-Chan Kim; Joo-Young Chung; Seong-Wook Hong; Kil-Hwan Choi; Young-Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2010-02-28

5.  Milrinone: is bolus bad?

Authors:  Venugopal Kulkarni
Journal:  Ann Card Anaesth       Date:  2018 Apr-Jun

6.  Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.

Authors:  Mai Mohsen Abdelazziz; Hadil Magdi Abdelhamid
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.